FindTrial
Sign In

Predicting survival of advanced stage cancer patients by simple prognostic score method

"Developing a simple outpatient prognostic score for prediction of survival Patients with advanced cancer".

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/12/010807
Enrollment
360
Registered
2017-12-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Metastatic Breast Cancer, Recurrent ca Ovary and also Metastatic Gall Bladder, Pancreas & Gastric cancer

Interventions

None listed

Sponsors

Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with advanced metastatic solid tumours: 1)Metastatic breast cancer who have received at least 2 lines of chemotherapy in metastatic setting and progressed thereafter. 2)Recurrent ovarian cancer who have received at least 2 lines of chemotherapy for recurrent disease and progressed thereafter 3)Gastric/Gall bladder/Pancreatic cancer patients who have received at least 1 line of chemotherapy and progressed thereafter

Exclusion criteria

Exclusion criteria: Not willing to consent for participation or not willing to be followed-up

Design outcomes

Primary

MeasureTime frame
Overall survivalTimepoint: Every 3 months from enrollements in study upto 2 years—

Secondary

MeasureTime frame
Overall survivalTimepoint: Every 3 months from enrollements in study upto 2 years—

Countries

India

Contacts

Public ContactMr Yogesh Kembhavi

Tata Memorial Centre

sudeepgupta04@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026